Clinical Evaluation of Day and Night Skin Care Creams Supplemented With MediCell Technology (MCT)'s Composition of Defensins and Supportive Molecules

Completed · Phase 4 · Has a placebo group

Conditions studied: Skin Aging, Photoaging of Skin

In brief

This is a placebo-controlled blinded clinical evaluation of day and night skin care creams supplemented by Medicell Technology's composition of defensins and supportive molecules determine the skin hydration and anti-aging properties of the topical test articles after repeated application to the skin of human subjects.

Key facts

Study ID

NCT02765763

Run by

Advanced Dermatology

People needed

45

Starts

2016-05-01

Expected to finish

2017-06-01

Last updated by the study team

2018-01-11

Who can join

Age: 40 and older, up to 75. Sex: female. Healthy volunteers: accepted.

You may qualify if…

• Sex: Female
• Fitzpatrick Skin Types: I-VI
• Age: 40 - 75 years
• Individuals who will be able to read, understand and give an informed consent relation to the study they are participating in.
• Individuals who will be free of any dermatological or systemic disorder, which in the Principal Investigator's opinion, could interfere with the study results.
• Individuals who will be in general good health and who will complete a preliminary medical history form mandated by the clinic.
• Individuals who will be able to and agree to cooperate with the Investigator and research staff.
• Individuals who will agree to have test products applied in accordance with the protocol and are able to complete the full course of the study.
• Individuals who will agree to have 2 biopsies on the postauricular area if randomly selected.
• Individuals who will agree to not participate in any other study during the entire length of the study and have not participated in a similar study in the past 30 days.

You may not qualify if…

• Individuals who are currently taking any medications (topical or systemic) that may mask or interfere with the test results.
• Individuals who have a history of any acute or chronic disease that might interfere with or increase the risk on study participation. (e.g., systemic lupus erythematosus, rheumatoid arthritis, HIV positive).
• Individuals who are diagnosed with chronic skin allergies (atopic dermatitis/eczema) or recently treated skin cancer within the last 12 months.
• Individuals who control their diabetes using insulin.
• Individuals with any history, which in the Investigator's opinion, indicates the potential for harm to the subject or places the validity of the study in jeopardy.
• Individuals who indicate that they are pregnant or are planning to become pregnant or nursing.
• Individuals who have undergone any of the following procedures:
• Botox within 6 months before enrollment into study and until study completion
• Injectable filler within 3 months before enrollment into study and until study completion
• Lasers or tissue tightening devices (ultherapy, radiofrequency, skin tightening, microcurrent or photorejuvenation, photodynamic therapy) within 6 months before enrollment into study and until study completion
• Sculptra or Bellafill prior to enrollment into the study and until study completion

Where it is running

• Advanced Dermatology, LLC — Lincolnshire, Illinois, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.